Market Cap N/A
Revenue (ttm) 390.40M
Net Income (ttm) -11.93M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -3.06%
Debt to Equity Ratio N/A
Volume 2,821,941
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founde...

Industry: Health Information Services
Sector: Healthcare
Phone: 415 726 2206
Address:
455 Market Street, Suite 700, San Francisco, United States
WallStreetScout1
WallStreetScout1 Jul. 14 at 6:58 PM
Portfolio update: Closed my $HNGE position today for an average return of +45%. I originally built it as an ~8% position, which eventually grew to 12-13% of my portfolio. It was one of the fastest-moving names I owned this year, and I’m very happy with the result. Over the past few weeks, I’ve rotated into selective opportunities across software, storage, and semiconductors. Closed positions: $MRVL → ~+150% average return $ARM → ~+150% average return $STM → -9% loss Current portfolio allocation (14 positions): Software / Platforms: 35% Semiconductors: 35% Robotics: 11% Growth: 10% Healthcare: 11% The next market leaders won’t come from one sector alone. The companies that combine strong fundamentals, durable growth, and favorable technical setups are the ones I believe will stand out. Follow my page for more portfolio updates, AI, semiconductor, and growth stock ideas.
0 · Reply
CosmicMiner
CosmicMiner Jul. 14 at 6:36 PM
Closed out the $HNGE position today for a solid +45% average gain. It grew into a 12-13% portfolio allocation before locking in profits. Also wrapping up recent moves in $MRVL (+150%), $ARM, and$STM (-9%) while shifting capital into software, storage, and semis.Portfolio allocation is now balanced: Software 35%, Semis 35%, Robotics 11%, Growth 10%, Healthcare 11%. Staying disciplined on high-quality fundamentals and strong price action.The next setup is forming. Timing matters more than speed. What sector are you rotating into next?
0 · Reply
WhaleTracker_
WhaleTracker_ Jul. 14 at 6:36 PM
Closed my $HNGE position today with an average gain of +45%. Started this as an ~8% portfolio allocation, and after the move it grew into a 12-13% position. One of the strongest performers I’ve held this year, and I’m happy locking in the win. Recently I’ve been rotating capital into selective software, storage, and semiconductor names while trimming positions like $MRVL and $ARM after strong runs, banking around +150% average returns. Also took a small hit on $STM at -9%. Current portfolio focus (14 positions): Software / Platforms: 35% Semiconductors: 35% Robotics: 11% Growth: 10% Healthcare: 11% The market leaders will be the companies combining strong fundamentals with strong technical setups. Sector doesn’t matter as much as execution.
0 · Reply
cokespo0n
cokespo0n Jul. 14 at 4:05 PM
$HNGE Little engine that could
0 · Reply
MorganHoratio
MorganHoratio Jul. 13 at 4:27 PM
While the market is pulling back, always pay attention to relative strength. Quite a few names continue to show impressive resilience. $TWLO $HNGE $ATEN $FROG $LLY Relative strength speaks volumes! As the market pulls back, which resilient ticker holds the ultimate long-term potential? $LLY & $HNGE: The powerhouse of healthcare. Eli Lilly (LLY) secures a massive empire via its heavyweight obesity pipeline. Digital health rising star Hinge Health (HNGE) displays elite strength, bucking the macro drift near all-time highs on blowout growth. $ATEN, $TWLO,$FROG: Indispensable infrastructure. A10 Networks (ATEN) acts as a premier secure delivery anchor for AI and crypto traffic. Twilio (TWLO) and JFrog (FROG) weaponize highly sticky developer and cloud-communication pipelines to secure recurring growth. I suggest you read my article over them. It is entirely free. You may be able to get some insight
0 · Reply
Stocktwits
Stocktwits Jul. 13 at 4:27 PM
$HNGE chart courtesy of @gpaisa
0 · Reply
gpaisa
gpaisa Jul. 13 at 4:10 PM
$HNGE continues to beast, but probably needs rest.
0 · Reply
FibonacciTrader_
FibonacciTrader_ Jul. 13 at 3:46 PM
Healthcare is quietly building leadership. While much of the market is focused on AI and semis, several healthcare growth names continue to show strong Stage 2 uptrend characteristics backed by improving price action and solid fundamentals. My radar includes: $OSCR $HNGE $ASTH $HIMS These stocks continue to print higher highs, defend key moving averages, and attract institutional interest. If this sector rotation continues, healthcare could become one of the market's next leadership groups. Don't wait until everyone is talking about them-watch where the money is flowing before the headlines catch up.
0 · Reply
SwingTraderPro1
SwingTraderPro1 Jul. 12 at 8:56 PM
Emerging mid-cap names are starting to show some interesting technical setups. Keeping an eye on $ASTH, $LMND, $BB, and $HNGE as several are building constructive patterns - including cup-and-handle formations, higher highs/higher lows, and potential transitions into new Stage 2 uptrends. These are the types of charts that can attract attention when momentum returns and breakouts are confirmed with volume. Not every setup will work, but strong bases often create the foundation for the next major move. Adding these names to the watchlist and waiting for confirmation.
0 · Reply
ApeFeces
ApeFeces Jul. 10 at 1:41 PM
$SOFI is now in my top 5 holdings 👀 1) $AMD 2) $ELF 3) $RDDT 4) $HNGE 5) SOFI
1 · Reply
Latest News on HNGE
Hinge Health price target raised to $65 from $55 at Baird

2026-06-17T10:21:48.000Z - 27 days ago

Hinge Health price target raised to $65 from $55 at Baird


Hinge Health price target raised to $76 from $65 at Canaccord

2026-06-15T10:42:46.000Z - 4 weeks ago

Hinge Health price target raised to $76 from $65 at Canaccord


Hinge Health price target raised to $90 from $75 at KeyBanc

2026-06-12T10:35:36.000Z - 4 weeks ago

Hinge Health price target raised to $90 from $75 at KeyBanc


Hinge Health price target raised to $85 from $79 at Truist

2026-06-11T13:40:33.000Z - 4 weeks ago

Hinge Health price target raised to $85 from $79 at Truist


Hinge Health price target raised to $76 from $63 at Needham

2026-06-11T11:23:50.000Z - 4 weeks ago

Hinge Health price target raised to $76 from $63 at Needham


Hinge Health price target raised to $70 from $62 at Barclays

2026-06-11T09:33:33.000Z - 4 weeks ago

Hinge Health price target raised to $70 from $62 at Barclays


Hinge Health Transcript: Investor Day 2026

Jun 10, 2026, 2:00 PM EDT - 4 weeks ago

Hinge Health Transcript: Investor Day 2026


Hinge Health Press release: FY 2026

Jun 10, 2026, 2:00 PM EDT - 4 weeks ago

Hinge Health Press release: FY 2026


Hinge Health Slides: FY 2026

Jun 10, 2026, 2:00 PM EDT - 4 weeks ago

Hinge Health Slides: FY 2026


Hinge Health adds orthopedic surgery to HingeSelect

2026-06-10T13:32:22.000Z - 4 weeks ago

Hinge Health adds orthopedic surgery to HingeSelect


Hinge Health price target raised to $79 from $67 at Stifel

2026-06-10T10:40:35.000Z - 4 weeks ago

Hinge Health price target raised to $79 from $67 at Stifel


Hinge Health hosts its first Investor Day and raises guidance

Jun 9, 2026, 4:05 PM EDT - 5 weeks ago

Hinge Health hosts its first Investor Day and raises guidance


Hinge Health Transcript: AGM 2026

Jun 3, 2026, 12:00 PM EDT - 5 weeks ago

Hinge Health Transcript: AGM 2026


Hinge Health Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Hinge Health Earnings Call Transcript: Q1 2026


Hinge Health Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Hinge Health Earnings release: Q1 2026


Hinge Health Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Hinge Health Slides: Q1 2026


Hinge Health Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 2 months ago

Hinge Health Quarterly report: Q1 2026


Hinge Health launches comprehensive Migraine Care Program

Apr 29, 2026, 10:00 AM EDT - 2 months ago

Hinge Health launches comprehensive Migraine Care Program


Hinge Health Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 3 months ago

Hinge Health Proxy statement: Proxy filing


Hinge Health Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 3 months ago

Hinge Health Proxy statement: Proxy filing


Hinge Health appoints Tyler Sloat to its board of directors

Mar 17, 2026, 4:05 PM EDT - 4 months ago

Hinge Health appoints Tyler Sloat to its board of directors


Hinge Health Earnings Call Transcript: Q4 2025

Feb 10, 2026, 4:30 PM EST - 5 months ago

Hinge Health Earnings Call Transcript: Q4 2025


Hinge Health Annual report: Q4 2025

Feb 10, 2026, 4:30 PM EST - 5 months ago

Hinge Health Annual report: Q4 2025


Hinge Health Earnings release: Q4 2025

Feb 10, 2026, 4:30 PM EST - 5 months ago

Hinge Health Earnings release: Q4 2025


Hinge Health Slides: Q4 2025

Feb 10, 2026, 4:30 PM EST - 5 months ago

Hinge Health Slides: Q4 2025


Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%

Nov 24, 2025, 11:00 AM EST - 8 months ago

Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%


Hinge Health announces $250 million share repurchase program

Nov 12, 2025, 9:00 AM EST - 8 months ago

Hinge Health announces $250 million share repurchase program


Hinge Health Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 9 months ago

Hinge Health Earnings Call Transcript: Q3 2025


Hinge Health Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 9 months ago

Hinge Health Quarterly report: Q3 2025


Hinge Health Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 9 months ago

Hinge Health Earnings release: Q3 2025


Hinge Health Slides: Q3 2025

Nov 4, 2025, 4:30 PM EST - 9 months ago

Hinge Health Slides: Q3 2025


Hinge Health reports third quarter 2025 financial results

Nov 4, 2025, 4:05 PM EST - 9 months ago

Hinge Health reports third quarter 2025 financial results


Hinge Health unveils new AI-powered care tools

Oct 21, 2025, 11:00 AM EDT - 9 months ago

Hinge Health unveils new AI-powered care tools


Hinge Health Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Hinge Health Earnings Call Transcript: Q2 2025


Hinge Health Quarterly report: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Hinge Health Quarterly report: Q2 2025


Hinge Health Earnings release: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Hinge Health Earnings release: Q2 2025


Hinge Health Slides: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 1 year ago

Hinge Health Slides: Q2 2025


Hinge Health Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 4:05 PM EDT - 1 year ago

Hinge Health Reports Second Quarter 2025 Financial Results


Hinge Health Goes Public, Raising $437M for Investors

May 22, 2025, 3:19 PM EDT - 1 year ago

Hinge Health Goes Public, Raising $437M for Investors


Hinge Health raises $437.3 million in US IPO

May 21, 2025, 7:15 PM EDT - 1 year ago

Hinge Health raises $437.3 million in US IPO


Hinge Health prices IPO at $32, the top end of expected range

May 21, 2025, 6:26 PM EDT - 1 year ago

Hinge Health prices IPO at $32, the top end of expected range


Hinge Health Announces Pricing of Initial Public Offering

May 21, 2025, 6:21 PM EDT - 1 year ago

Hinge Health Announces Pricing of Initial Public Offering


Hinge Health Registration statement: Registration Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

Hinge Health Registration statement: Registration Filing


Hinge Health Aims to Raise $437 Million in IPO

May 13, 2025, 1:00 PM EDT - 1 year ago

Hinge Health Aims to Raise $437 Million in IPO


Hinge Health Announces Launch of Initial Public Offering

May 13, 2025, 8:40 AM EDT - 1 year ago

Hinge Health Announces Launch of Initial Public Offering


Hinge Health Registration statement: Registration Filing

May 13, 2025, 8:00 AM EDT - 1 year ago

Hinge Health Registration statement: Registration Filing


Hinge Health targets $2.6 billion valuation in NYSE IPO

May 13, 2025, 6:46 AM EDT - 1 year ago

Hinge Health targets $2.6 billion valuation in NYSE IPO


Hinge Health Registration statement: Registration Filing

May 5, 2025, 8:00 AM EDT - 1 year ago

Hinge Health Registration statement: Registration Filing


WallStreetScout1
WallStreetScout1 Jul. 14 at 6:58 PM
Portfolio update: Closed my $HNGE position today for an average return of +45%. I originally built it as an ~8% position, which eventually grew to 12-13% of my portfolio. It was one of the fastest-moving names I owned this year, and I’m very happy with the result. Over the past few weeks, I’ve rotated into selective opportunities across software, storage, and semiconductors. Closed positions: $MRVL → ~+150% average return $ARM → ~+150% average return $STM → -9% loss Current portfolio allocation (14 positions): Software / Platforms: 35% Semiconductors: 35% Robotics: 11% Growth: 10% Healthcare: 11% The next market leaders won’t come from one sector alone. The companies that combine strong fundamentals, durable growth, and favorable technical setups are the ones I believe will stand out. Follow my page for more portfolio updates, AI, semiconductor, and growth stock ideas.
0 · Reply
CosmicMiner
CosmicMiner Jul. 14 at 6:36 PM
Closed out the $HNGE position today for a solid +45% average gain. It grew into a 12-13% portfolio allocation before locking in profits. Also wrapping up recent moves in $MRVL (+150%), $ARM, and$STM (-9%) while shifting capital into software, storage, and semis.Portfolio allocation is now balanced: Software 35%, Semis 35%, Robotics 11%, Growth 10%, Healthcare 11%. Staying disciplined on high-quality fundamentals and strong price action.The next setup is forming. Timing matters more than speed. What sector are you rotating into next?
0 · Reply
WhaleTracker_
WhaleTracker_ Jul. 14 at 6:36 PM
Closed my $HNGE position today with an average gain of +45%. Started this as an ~8% portfolio allocation, and after the move it grew into a 12-13% position. One of the strongest performers I’ve held this year, and I’m happy locking in the win. Recently I’ve been rotating capital into selective software, storage, and semiconductor names while trimming positions like $MRVL and $ARM after strong runs, banking around +150% average returns. Also took a small hit on $STM at -9%. Current portfolio focus (14 positions): Software / Platforms: 35% Semiconductors: 35% Robotics: 11% Growth: 10% Healthcare: 11% The market leaders will be the companies combining strong fundamentals with strong technical setups. Sector doesn’t matter as much as execution.
0 · Reply
cokespo0n
cokespo0n Jul. 14 at 4:05 PM
$HNGE Little engine that could
0 · Reply
MorganHoratio
MorganHoratio Jul. 13 at 4:27 PM
While the market is pulling back, always pay attention to relative strength. Quite a few names continue to show impressive resilience. $TWLO $HNGE $ATEN $FROG $LLY Relative strength speaks volumes! As the market pulls back, which resilient ticker holds the ultimate long-term potential? $LLY & $HNGE: The powerhouse of healthcare. Eli Lilly (LLY) secures a massive empire via its heavyweight obesity pipeline. Digital health rising star Hinge Health (HNGE) displays elite strength, bucking the macro drift near all-time highs on blowout growth. $ATEN, $TWLO,$FROG: Indispensable infrastructure. A10 Networks (ATEN) acts as a premier secure delivery anchor for AI and crypto traffic. Twilio (TWLO) and JFrog (FROG) weaponize highly sticky developer and cloud-communication pipelines to secure recurring growth. I suggest you read my article over them. It is entirely free. You may be able to get some insight
0 · Reply
Stocktwits
Stocktwits Jul. 13 at 4:27 PM
$HNGE chart courtesy of @gpaisa
0 · Reply
gpaisa
gpaisa Jul. 13 at 4:10 PM
$HNGE continues to beast, but probably needs rest.
0 · Reply
FibonacciTrader_
FibonacciTrader_ Jul. 13 at 3:46 PM
Healthcare is quietly building leadership. While much of the market is focused on AI and semis, several healthcare growth names continue to show strong Stage 2 uptrend characteristics backed by improving price action and solid fundamentals. My radar includes: $OSCR $HNGE $ASTH $HIMS These stocks continue to print higher highs, defend key moving averages, and attract institutional interest. If this sector rotation continues, healthcare could become one of the market's next leadership groups. Don't wait until everyone is talking about them-watch where the money is flowing before the headlines catch up.
0 · Reply
SwingTraderPro1
SwingTraderPro1 Jul. 12 at 8:56 PM
Emerging mid-cap names are starting to show some interesting technical setups. Keeping an eye on $ASTH, $LMND, $BB, and $HNGE as several are building constructive patterns - including cup-and-handle formations, higher highs/higher lows, and potential transitions into new Stage 2 uptrends. These are the types of charts that can attract attention when momentum returns and breakouts are confirmed with volume. Not every setup will work, but strong bases often create the foundation for the next major move. Adding these names to the watchlist and waiting for confirmation.
0 · Reply
ApeFeces
ApeFeces Jul. 10 at 1:41 PM
$SOFI is now in my top 5 holdings 👀 1) $AMD 2) $ELF 3) $RDDT 4) $HNGE 5) SOFI
1 · Reply
Nasdaq_Frontier
Nasdaq_Frontier Jul. 9 at 5:08 PM
The market is not just a handful of AI/memory names. There are many other sectors and stocks acting incredibly well that most investors are missing. The rally has broadened far beyond the obvious AI and memory trade. Here are some of the key sectors and names to watch: Biotech/Healthcare $ERAS $IBRX $ABCL $QURE $HNGE The macro landscape is structurally shifting! Smart money is actively broadening the rally, rotating out of overcrowded AI and memory nodes into deeply discounted, hyper-growth Biotech and Healthcare assets. These listed names represent the ultimate asymmetric frontrunners of this rotation. We are looking at massive institutional accumulation in IBRX following its oncology pipeline acceleration, alongside gene-therapy pioneer QURE which delivered multi-bagger returns on breakthrough FDA regulatory paths. Meanwhile, platforms like ABCL and ERAS are seeing intense volume expansion ahead of crucial data readouts. As the market pivots from pure hardware infrastructure toward growth diversification, biotech is emerging as the premier destination for high-conviction alpha. Is this biotech surge a tactical, near-term capital pitstop, or the start of a multi-year secular bull run for healthcare? Which high-reward play are you backing for the next leg up: ERAS, IBRX, ABCL, QURE, or HNGE? Let's talk shop below!
0 · Reply
howardlindzon
howardlindzon Jul. 9 at 3:40 PM
$HNGE damn.,..a trend I missed so far - breakout was back In april - NO friends still almost doubled
0 · Reply
FibonacciTrader_
FibonacciTrader_ Jul. 8 at 3:57 PM
Quick reminder: big winners often come from having conviction before the crowd catches on. Recent performance snapshot shows how powerful the right setups can be - while not every trade works, the strongest names can create outsized moves. Performance watch: $HNGE → +78% $DDOG → +77% $NAVN → +50% $SNPS → -13% Average move: +48% Markets are always rotating. The key is staying focused on strong trends, managing risk, and finding opportunities before they become obvious to everyone. Next alert is coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.
2 · Reply
Avocado_smash
Avocado_smash Jul. 6 at 5:31 PM
$HNGE Look at this ✅
0 · Reply
Vilhelm_gr8
Vilhelm_gr8 Jul. 6 at 4:08 PM
$HNGE planned not to buy, but fomo-me cant miss this rally, so back here again with a fairly large position 😆
0 · Reply
FibonacciTrader_
FibonacciTrader_ Jul. 6 at 4:03 PM
$HNGE - one of the stronger contributors in my book this year outside the semis space. Position is already up ~45% from entry, initially sized at ~8% allocation, which is meaningful exposure for a $5B-type name. I don’t usually press size like that unless both fundamentals and structure align. The key takeaway here isn’t just performance - it’s the process behind it. Early-stage IPOs often get ignored or mispriced because liquidity and sentiment are still developing. But when you see a combination of: • Strong forward growth trajectory (20%+ revenue/EPS expansion assumptions) • High-quality margins (70%+ gross margin profile with improving operating leverage) • Clean technical structure (IPO base formation, institutional accumulation, holding above VWAP) That’s where asymmetric setups tend to form before broader market recognition. $HNGE is a reminder that leadership often builds quietly before it becomes obvious.
0 · Reply
WhaleTracker_
WhaleTracker_ Jul. 6 at 2:54 PM
$HNGE One of the stronger additions this year outside of semis for me. Position is already up ~45% since entry, originally sized at ~8% allocation. I don’t usually let a ~$5B market cap name become that meaningful in the portfolio unless both the fundamentals and price action are aligned. The key takeaway from $HNGE for me has been simple: don’t ignore younger IPOs just because they’re early. The setups that tend to matter most usually have a mix of sustained revenue/EPS growth expectations, strong margin structure, and clear institutional accumulation showing up in the chart (IPO base, VWAP reclaim, trend continuation). When those elements line up, you often find leadership names well before the broader market agrees.
0 · Reply
Rolex53
Rolex53 Jul. 6 at 2:51 PM
$CLOV $HNGE was keep on running. No matter whether it is red or green day. Why can't we ?
0 · Reply
FibonacciTrader_
FibonacciTrader_ Jul. 5 at 11:28 PM
IPO leadership watchlist - early-stage names showing accumulation while price holds above key reference levels like IPO VWAP. $HNGE - emerging IPO base forming, watching for breakout confirmation $NAVN -steady institutional accumulation, trend still early $PTRN - tightening range, potential expansion setup $MDLN - post-IPO structure holding, buyers still active Strong IPOs don’t wait for confirmation headlines. They build bases quietly, then break when liquidity rotates in. Ignoring early accumulation phases is where most miss the next market leaders. Sharing framework and levels - no paywall, just structured positioning thinking
0 · Reply
Avocado_smash
Avocado_smash Jul. 2 at 4:16 AM
$HNGE Good
0 · Reply
Rolex53
Rolex53 Jul. 2 at 12:22 AM
$CLOV $HNGE 85 guys. $CLOV atleast 7 please.
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jun. 30 at 9:55 PM
$HNGE Still bossing
0 · Reply